EBV Specific T-Lymphocytes for Treatment of EBV-Positive Lymphoma
EBV Specific T-Lymphocytes for Treatment of EBV-Positive Lymphoma
Recruiting · NCT04664179 · Registry updated 2026-06-25Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| EBV Specific T-Lymphocytes for Treatment of EBV-Positive Lymphoma | DNA Virus Infections, Epstein-Barr virus infection, Hemic and Lymphatic Diseases, Herpesviridae infectious disease, Hodgkins lymphoma, Infections, Neoplasms by Histologic Type, Tumor Virus Infections, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm, viral infectious disease | Recruiting | Phase 1 | 2026-06-25 | NCT04664179 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Baylor College of Medicine | 267 |
| National Cancer Institute (NCI) | 3015 |
| The Methodist Hospital Research Institute | 124 |
4 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Baylor St. Luke's Medical Center | Houston | United States | 1 |
| Harris Health System - Ben Taub General Hospital/Smith Clinic | Houston | United States | 1 |
| Houston Methodist Hospital | Houston | United States | 260 |
| Texas Children's Hospital | Houston | United States | 187 |